Document is current
Any future updates will be listed below
-
Authors
Silva-Rodríguez, Jesús
Castro, Cristina
Cortés, Julia
Arias, Manuel
Pubul, Virginia
Moscoso, Alexis
Grothe, Michel J.
Reynes-Llompart, Gabriel
Rodríguez-Bel, Laura
Gascon-Bayarri, Jordi
Sobrido, María Jesús
Aguiar, Pablo https://orcid.org/0000-0002-7322-2195
-
Funding
Funding for this research was provided by:
Interreg (EAPA_791/2018)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 14 February 2025
First Online: 26 February 2025
Declarations
:
: This study was approved by the Ethics Committee Xunta de Galicia (reference XUNTA 2015/140), registered 21 April 2015 and complied with the declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: This study was funded by Actelion Pharmaceuticals Ltd, makers of Zavesca (miglustat). JSR and PA are consultants for Qubiotech Health Intelligence SL. No other potential conflicts of interest relevant to this article exist.
